Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction.
OBJECTIVE
To assess platelet activation after thrombolysis in patients with acute myocardial infarction.


METHODS
Platelet function was assessed by measurement of the in vivo synthesis of thromboxane by gas chromatography-mass spectrometry of thromboxane's major urinary metabolite, 2,3-dinor-thromboxane-B2.


METHODS
Coronary care unit of Huddinge University Hospital.


METHODS
30 patients with acute myocardial infarction given either streptokinase 1.5 million units intravenously over one hour + 500 mg aspirin (n = 10), 500 mg aspirin (n = 10), or neither thrombolysis nor aspirin (n = 10).


RESULTS
Patients treated by thrombolysis had a 20-fold increase in thromboxane formation during thrombolysis compared with control patients not treated by thrombolysis (p = 0.0001). Until two days after thrombolysis thromboxane production in patients treated with streptokinase did not decrease to a value comparable with patients treated with aspirin but not given thrombolysis.


CONCLUSIONS
Thromboxane production increased considerably during thrombolysis, possibly reflecting greatly enhanced platelet activation. The slow decrease in thromboxane formation after treatment with aspirin suggests that the efficacy of thrombolysis might be improved by more efficient antiplatelet treatment.
Rasmanis
G
G
Department of Medicine, Karolinska Institutet, Huddinge University Hospital, Stockolm, Sweden.
Vesterqvist
O
O
Gréen
K
K
Edhag
O
O
Henriksson
P
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D015539:Platelet Activation; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D013929:Thromboxane B2 / Q000031:analogs & derivatives / Q000378:metabolism; D013931:Thromboxanes / Q000378:metabolism*
D013931:Thromboxanes; D013929:Thromboxane B2; C028965:2,3-dinor-thromboxane B2; D013300:Streptokinase; D001241:Aspirin